Matches in Wikidata for { <http://www.wikidata.org/entity/Q91991783> ?p ?o ?g. }
- Q91991783 description "article scientifique publié en 2017" @default.
- Q91991783 description "artículu científicu espublizáu en payares de 2017" @default.
- Q91991783 description "im November 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91991783 description "scientific article published on 24 November 2017" @default.
- Q91991783 description "wetenschappelijk artikel" @default.
- Q91991783 description "наукова стаття, опублікована в листопаді 2017" @default.
- Q91991783 name "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 name "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 type Item @default.
- Q91991783 label "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 label "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 prefLabel "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 prefLabel "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 P1433 Q91991783-9C31DFCC-3958-48BE-8871-08A9051F2BC8 @default.
- Q91991783 P1476 Q91991783-ED340D13-6572-48B4-A70F-1D86CEE933AA @default.
- Q91991783 P2093 Q91991783-0BD40309-7C1C-41A0-A25E-D9E8C3E9156A @default.
- Q91991783 P2093 Q91991783-126C5D5F-156C-43C1-A911-24A4899C8F6B @default.
- Q91991783 P2093 Q91991783-1B8D030B-7658-41B3-9FAB-585E1A7EB1F8 @default.
- Q91991783 P2093 Q91991783-2568E414-64A2-428F-BB55-47648E935698 @default.
- Q91991783 P2093 Q91991783-2C934164-C8D6-4644-A1B8-4F90B8641CD3 @default.
- Q91991783 P2093 Q91991783-341CBB3B-454F-4606-BA65-C3E62B1B4A93 @default.
- Q91991783 P2093 Q91991783-34800C32-4C9D-4F3A-B19E-F381492917DF @default.
- Q91991783 P2093 Q91991783-5298B8A2-500F-49E8-9455-D3B12BBF460C @default.
- Q91991783 P2093 Q91991783-8CEC0286-DD96-4C3E-B758-F4D43A917709 @default.
- Q91991783 P2093 Q91991783-BF18D513-5C45-4BA2-960C-D748516D637F @default.
- Q91991783 P2093 Q91991783-C032C894-DB2C-42CA-9EB8-49F279FE1A68 @default.
- Q91991783 P2093 Q91991783-C52CE38E-A273-4D75-B63D-19BF85F54AB8 @default.
- Q91991783 P2093 Q91991783-C7531E98-D243-4647-804B-DEF9F29714CE @default.
- Q91991783 P2093 Q91991783-D3997338-75A2-4F09-BD5E-8AA372A5AED9 @default.
- Q91991783 P2860 Q91991783-022BCBE0-3FAD-453F-AAE6-E7AF0B320248 @default.
- Q91991783 P2860 Q91991783-12BF00D8-712B-4583-A116-B0097BA0E08A @default.
- Q91991783 P2860 Q91991783-1825A312-22CF-41B8-A1F1-A7C782BDF059 @default.
- Q91991783 P2860 Q91991783-3077499E-CAEE-4AB5-9379-56E4010C90C3 @default.
- Q91991783 P2860 Q91991783-36A3B04B-FC68-4EED-829A-8C29D7107BF2 @default.
- Q91991783 P2860 Q91991783-4444AB8F-F630-4F6A-B9D2-253DF84AADD2 @default.
- Q91991783 P2860 Q91991783-46B23DE0-78EC-4EAE-8D81-480C1A6825CB @default.
- Q91991783 P2860 Q91991783-54A679E8-FCB9-43C5-87DC-E1A9ED183B2A @default.
- Q91991783 P2860 Q91991783-5B9136E5-E619-468B-8307-DF772FE5DEFF @default.
- Q91991783 P2860 Q91991783-67814614-05BA-4E56-B0B6-4B0891AC37E3 @default.
- Q91991783 P2860 Q91991783-6C53F4CC-ACB1-4B0A-981B-A9F4A02774F1 @default.
- Q91991783 P2860 Q91991783-6EDC3E21-827E-439D-876C-7F214BACA202 @default.
- Q91991783 P2860 Q91991783-6F270A2B-88C0-4DEF-A55B-B2A601C3197A @default.
- Q91991783 P2860 Q91991783-75122940-547B-405C-AA50-D4D8A337F2EE @default.
- Q91991783 P2860 Q91991783-920E9B98-8019-4D00-870B-38051D410FD9 @default.
- Q91991783 P2860 Q91991783-B79FD6A4-1F77-4A56-894F-BD8814E83998 @default.
- Q91991783 P2860 Q91991783-BE677BDB-0573-451A-9F59-C04569757DDA @default.
- Q91991783 P2860 Q91991783-C0394E1E-381A-4A69-895A-CC6A6D0D9E89 @default.
- Q91991783 P2860 Q91991783-D40C7BA6-897E-46B0-B6AD-E102ACE5C025 @default.
- Q91991783 P2860 Q91991783-D7E7FC25-6902-476D-AAA7-AAAC813169CB @default.
- Q91991783 P2860 Q91991783-EE59F6AE-7C24-464E-8438-D5A39AC810DF @default.
- Q91991783 P2860 Q91991783-F622D573-467C-4EEC-B68F-4CDAA99A2DAD @default.
- Q91991783 P2860 Q91991783-F7674100-4C53-44E8-988C-588CA15B4DE7 @default.
- Q91991783 P2860 Q91991783-FD554CCC-E38A-446A-8AAB-E6052AD7E7BA @default.
- Q91991783 P304 Q91991783-455C9087-9DA3-4609-A882-D7A147FA4390 @default.
- Q91991783 P31 Q91991783-A1A483CB-77C1-4471-8091-B64E263855A7 @default.
- Q91991783 P356 Q91991783-B3FBCCDA-6B9C-4056-9F82-536C20EDD6E1 @default.
- Q91991783 P433 Q91991783-3BF26BB9-98DD-4E67-A618-89B5739DDA57 @default.
- Q91991783 P478 Q91991783-6E7FD4D6-0F74-47BB-A719-A03DB6D1A4E2 @default.
- Q91991783 P50 Q91991783-2D8FEEB2-48F1-4E25-975E-9EB4FD0897B6 @default.
- Q91991783 P577 Q91991783-7D4BB53E-8A1F-4F46-8102-6954C3994A16 @default.
- Q91991783 P698 Q91991783-5B2DFE65-76CA-4FC4-9851-8CFA76F6CD49 @default.
- Q91991783 P921 Q91991783-1B9959FB-F1CC-458B-B37C-DB222E1317D1 @default.
- Q91991783 P932 Q91991783-304F9F7A-589A-42F8-A0CF-6A6579DE45C9 @default.
- Q91991783 P356 EDM2.2 @default.
- Q91991783 P698 30815539 @default.
- Q91991783 P1433 Q27725324 @default.
- Q91991783 P1476 "A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice" @default.
- Q91991783 P2093 "Alessandro Pocai" @default.
- Q91991783 P2093 "Ann E Weber" @default.
- Q91991783 P2093 "Daniel A Tatosian" @default.
- Q91991783 P2093 "George J Eiermann" @default.
- Q91991783 P2093 "Giovanna Scapin" @default.
- Q91991783 P2093 "Joel P Berger" @default.
- Q91991783 P2093 "Joseph K Wu" @default.
- Q91991783 P2093 "Kelly Ann D Pryor" @default.
- Q91991783 P2093 "Nancy A Thornberry" @default.
- Q91991783 P2093 "Ranabir SinhaRoy" @default.
- Q91991783 P2093 "Shiyao S Xu" @default.
- Q91991783 P2093 "Theresa M Kelly" @default.
- Q91991783 P2093 "Xiaoping Zhang" @default.
- Q91991783 P2093 "Ying-Duo Gao" @default.
- Q91991783 P2860 Q24529863 @default.
- Q91991783 P2860 Q27640163 @default.
- Q91991783 P2860 Q27642932 @default.
- Q91991783 P2860 Q27649174 @default.
- Q91991783 P2860 Q27649728 @default.
- Q91991783 P2860 Q27666424 @default.
- Q91991783 P2860 Q27684194 @default.
- Q91991783 P2860 Q27861090 @default.
- Q91991783 P2860 Q28262769 @default.
- Q91991783 P2860 Q30477923 @default.
- Q91991783 P2860 Q37176045 @default.
- Q91991783 P2860 Q37468406 @default.
- Q91991783 P2860 Q37813161 @default.
- Q91991783 P2860 Q38248682 @default.
- Q91991783 P2860 Q38644587 @default.
- Q91991783 P2860 Q43289696 @default.
- Q91991783 P2860 Q44474559 @default.
- Q91991783 P2860 Q44979431 @default.
- Q91991783 P2860 Q45212807 @default.